Access
To read this story in full you will need to login or make a payment (see right).
Opinion
Nature 418, 903 (29 August 2002) | doi:10.1038/418903a
Clones: oddities or businesses?
Top of page
Abstract
The woes of the biotechnology sector have been compounded by technical obstacles for companies seeking to develop cloning technologies. For benefits to materialize, scientific understanding needs fostering by industry and governments.
Poor Dolly. When the sheep was born in 1997, she was a symbol of the potential of the new technology of cloning.
To read this story in full you will need to login or make a payment (see right).